Go Pro
→ Buy These Stocks Before August 31st (From TradeSmith) (Ad)tc pixel Free SCTX Stock Alerts
NASDAQ:SCTX

Scribe Therapeutics (SCTX) Stock Price, News & Analysis

Scribe Therapeutics logo
$20.73 +0.36 (+1.77%)
As of 08/14/2026 04:00 PM Eastern

About Scribe Therapeutics Stock (NASDAQ:SCTX)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$19.09
▼
$21.46
50-Day Range
N/A
52-Week Range
$17.31
▼
$26.50
Volume
118,869 shs
Average Volume
242,667 shs
Market Capitalization
$364.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scribe Therapeutics Inc. is a clinical-stage biotechnology company engineering CRISPR-based technologies into purpose-built in vivo genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent diseases, starting with cardiometabolic disease. Scribe Therapeutics Inc. is based in ALAMEDA, Calif.

Receive SCTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scribe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SCTX Stock News Headlines

Scribe Therapeutics (NASDAQ:SCTX) Major Shareholder Bio Fund Ii L.P. Ah Buys 333,333 Shares of Stock
July 30, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-sctx-insider-buying-and-selling-2026-07-30/
David Parrot Purchases 2,666 Shares of Scribe Therapeutics (NASDAQ:SCTX) Stock
July 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-sctx-insider-buying-and-selling-2026-07-29/
Nvidia's CEO says this small device is critical for AI growth
A tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it essential for AI to scale, while Sequoia Capital labels it a holy grail. Stocks tied to this technology have already surged 133 percent, 217 percent, and 320 percent in recent months, according to Brownstone Research analyst Jason Bodner, who identified Nvidia at 4.50.tc pixel
August 16 at 1:00 AM  |  Brownstone Research (Ad)
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333869/0/en/scribe-therapeutics-announces-closing-of-initial-public-offering-full-exercise-of-underwriters-option-to-purchase-additional-shares-and-closing-of-the-concurrent-private-placement.html
See More Headlines

SCTX Stock Analysis - Frequently Asked Questions

Scribe Therapeutics' stock was trading at $21.65 on July 24, 2026. Since then, SCTX shares have decreased by 4.2% and is now trading at $20.73.

Scribe Therapeutics (SCTX) raised $120 million in an initial public offering on Friday, July 24th 2026. The company issued 8,580,000 shares at $13.00-$15.00 per share.

Scribe Therapeutics's quiet period expires on Wednesday, September 2nd. Scribe Therapeutics had issued 8,580,000 shares in its initial public offering on July 24th. The total size of the offering was $128,700,000 based on an initial share price of $15.00. During Scribe Therapeutics' quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of SCTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/16/2026
Fiscal Year End
12/31/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:SCTX
CIK
1853921
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
17,580,000
Free Float
N/A
Market Cap
$364.43 million
Optionable
N/A
Beta
N/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:SCTX) was last updated on 8/16/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Your 10X AI demo is starting…
Keith Kaplan, the AI expert behind tools used by more than 100000 investors, built his models with an investme...
TradeSmith | Sponsoredtc pixel
Why acquisitions are reshaping the gold mining sector right now
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel